Metformin displays in vitro and in vivo antitumor effect against osteosarcoma.

CONCLUSION: Further studies are necessary to explore metformin's therapeutic potential and the possibilities for its use as an adjuvant agent for osteosarcoma.
PMID: 27721842 [PubMed - in process]

Source: Korean Journal of Pediatrics - October 13, 2016 Category: Pediatrics Tags: Korean J Pediatr Source Type: research